Share Success: Letters From Readers
I: From Alan
Submit Form on Thursday, May 15, 2014 at 18:18:24
Hi, my name is Alan.
Two years ago (March 2012) I took a test called DEXA (Bone Density Test) to see if I had osteoporosis. The test results were I had osteoporosis in my spine, hip, and left arm.
The doctor was going to give me alendronate (fosamax) until I read the side effects. I was NOT going to take that medicine. So I went on the Internet and look for osteoporosis and I found EZorb.
I read up on EZorb. It had no side effects. So I took the powder for two years.
Then I took the test again (DEXA April 2014) and the results were I had no osteoporosis. EZorb worked. My doctor was surprised.
Many thanks for this wonderful product.
PS I turned 70 years in May 2014.
II: From Alain D.
at email@example.com on Monday, March 24, 2014 9:49 AM
I am about to reorder Marvlix for the third time: I find it has greatly helped my upper respiratory problem whereas I do not use at all the medicine (Advair250 inhaler). I am curious about how I might become a distributor?
III: From Jane J.
Submit Form on
Tuesday, January 28, 2014 at 09:15:17
Hi, my name is Jane Johnson, I wrote a letter about a year or so ago about how Ezorb totally healed my heel spur.
That was the most horrible pain I have ever had. Since I took Ezorb, my foot pain has never come back.
When I think how much a doctor would have charged to fix my foot pain, Ezorb is well worth the cost. Anyone who has any kind of body aches and pains, please buy Ezorb. You wont be disappointed.
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 70,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to firstname.lastname@example.org
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public.
Research News: IBS May Link to Bipolar Disorder
Researchers have found evidence that the gastrointestinal (GI) tract plays a role in the inflammatory pathology of bipolar disorder, suggesting the need to consider dietary modification and anti-inflammatory treatment for some patients.
Their results showed that elevated levels of anti-Saccharomyces cerevisiae antibodies (ASCA; a GI inflammation marker) were associated with a 3.5–4.4-fold increased risk for bipolar disorder, irrespective of what medications were being taken.
ASCA levels in the 264 bipolar disorder patients, 38 of whom had a recent onset of psychosis, were between 2.5 and 3.0 mean-normalized absorbance at 405 nm, compared with 1.0 in the 207 mentally healthy individuals.
Moreover, ASCA levels in patients correlated strongly with immunoglobulin G against wheat gluten and bovine milk caseins. These associations were particularly strong in patients with bipolar disorder who also reported GI symptoms, such as gastroesophageal reflux disease.
These findings support previous theories that compromised endothelial barriers in patients with bipolar disorder may allow exorphins, the by-products of gluten and casein digestion, to enter into systemic circulation and impact brain physiology through action at opioid receptors, the researchers, led by Emily Severance (Johns Hopkins University School of Medicine, Baltimore, Maryland, USA), explain.
However, the team also notes that as ASCA levels correlated with antibodies to food antigens in those with and without GI symptoms, there may be a nonspecific immune response occurring.
To investigate this further, they looked at correlations between ASCA levels and non-food-related antigens, including measles and Toxoplasma gondii, and found significant correlations in patients with bipolar disorder, but only those with recent onset psychosis.
"Although our findings require further scrutiny and larger sample sizes, the possibility of a more generalized inflammatory nature inherent to earlier stages of disease cannot be discounted," Severance et al write in Bipolar Disorders.
They believe that the serologic markers and their inter-associations could help to identify patients with bipolar disorder who may be at risk for GI- and food-based sensitivities. And they recommend: "Treatment strategies that involve dietary modifications, anti-inflammatory agents and/or microbiota modulations should be evaluated for effects on symptom improvement in carefully controlled clinical trials."
Original research was published in Bipolar Disord 2013; Advance online publication.
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to email@example.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.